Bristol Myers Squibb Company
https://www.bms.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bristol Myers Squibb Company
October Outlook For US FDA Approvals: Goal Dates Are Sparse, But Backlog Looms
Upcoming user fee goal dates include AstraZeneca’s tremelimumab, Amicus’ AT-GAA, and drug delivery technology-driven NDAs from Supernus/US Worldmeds and scPharmaceuticals
Cage Fighting: Novel Drugs From MNCs, Chinese Rivals Compete In China Reimbursement Sector
After slashing the prices of their blockbuster drugs to gain wider patient access through China's main reimbursement program, multinationals are now beginning to face increasing challenges from local competitors.
Biohaven’s Non-Migraine Portfolio Takes Another Hit As Verdiperstat Fails In ALS
Pfizer is buying Biohaven's migraine portfolio, but the rest of the pipeline is poised to be spun out and there have been two development setbacks. Despite verdiperstat's failure in ALS, the field had a same-day win with Amylyx's Relyvrio approval.
Big In Japan: Assessing Seven Years Of Sakigake
Japan’s fast-track approval system for innovative drug candidates has marked its seventh year since launch, during which it has accepted 27 candidates with 13 of these moving to approval. But in recent years the system has faced a decreasing number of admitted candidates, this original infographic analysis shows.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abraxis BioScience, Inc.
- AbVitro, Inc.
- Acetylon Pharmaceuticals, Inc.
- Adnexus Therapeutics, Inc.
- Allied-Bristol Life Sciences, LLC
- Amira Pharmaceuticals, Inc.
- Amylin Pharmaceuticals, Inc.
- Avila Therapeutics, Inc.
- Bristol-Myers Company
- Bristol-Myers K.K.
- Bristol-Myers Squibb
- Cardioxyl Pharmaceuticals
- Celgene Corporation
- Cormorant Pharmaceuticals
- Delinia, Inc.
- EngMab AG
- Flexus Biosciences, Inc.
- Gloucester Pharmaceuticals, Inc.
- ißeCa Therapeutics
- IFM Therapeutics
- Impact Biomedicines, Inc.
- Inhibitex, Inc.
- iPierian Inc.
- Juno Therapeutics, Inc.
- Juno Therapeutics GmbH (Stage Cell Therapeutics GmbH)
- JW Biotechnology (Shanghai) Co., Ltd
- Kosan
- Medarex, Inc.
- Padlock Therapeutics, Inc.
- Pharmion Corporation
- Quanticel Pharmaceuticals, Inc.
- Receptos, Inc.
- RedoxTherapies, Inc.
- Turning Point Therapeutics Inc.
- Westwood-Squibb Pharmaceuticals
- X-BODY, Inc.
- ZymoGenetics, Inc.
- Forbius
- MyoKardia Inc.